Breast Adenocarcinoma — Trials

Breast Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,713 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 686
Recruiting: 381
Ph III recruiting: 45
Growth YoY: +8.5%
Industry share: 24%
Top sponsor: Fudan University
Termination share: 44.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (278)

clinicaltrialsPublishedShowing 101–113 of 113 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02365714	CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)(CK-SAPBI)	terminated	Phase 1 / Phase 2	2	Georgetown UniversityOTHER	1	Apr 13, 2018	clinicaltrials
NCT02345772	Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy(Neohttp)	terminated	Phase 1 / Phase 2	4	Western Regional Medical CenterOTHER	1	Feb 20, 2018